Cocrystal Pharma Inc (COCP) Stock Price, Quote & News

Company Profile

Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases in the United States. It employs structure-based technologies to create antiviral drugs including influenza virus, coronaviruses, such as SARS-CoV-2 and MERS-CoV, as well as norovirus, respiratory virus infections, and hepatitis C virus (HCV) infections. The company develops CC-42344, a novel PB2 inhibitor, which is in phase 2a cl...

Industry: Biotechnology

Sector: Healthcare

Phone: 877 262 7123

Website: www.cocrystalpharma.com

Address:

19805 North Creek Parkway, Bothell, United States

elon_musk22 Apr. 7 at 12:13 PM

$COCP tick tock if you have or haven't seen a real short blowup stay tuned since No dilution is bitch slapping them in the deep pocket LMfaoooo

0 · Reply

TeamBullish Apr. 6 at 10:29 PM

$AIXI the $0.90 will drive this above the $1. Also watching $COCP $PFSA $CUPR $ADVB for tomorrow, we’re going to have some fun.

0 · Reply

Felaw Apr. 6 at 9:57 PM

$COCP tight range of 1.4 to 1.62. Looking for a breakout tomorrow.

0 · Reply

Rampageusa Apr. 6 at 9:34 PM

$COCP lets do 2 soon..

0 · Reply

Tigerlilly11 Apr. 6 at 9:03 PM

$COCP This morning, Cost-to-Borrow was 3.54 It is now 205.97

0 · Reply

TheBigK78 Apr. 6 at 8:56 PM

Took profits from $AIXI into $COCP. 💥💥

0 · Reply

cjstocksup Apr. 6 at 8:03 PM

$COCP We have big news events in April the short fry above should be epic.

1 · Reply

Rambu11 Apr. 6 at 8:01 PM

$COCP very bullish close. We Fight another day!

0 · Reply

Channelchek Apr. 6 at 7:58 PM

Noble Capital Markets Research Report: Cocrystal Pharma ($COCP) – CDI-988 Receives Fast Track Designation, Raising Its Profile Cocrystal Receives Fast Track Designation. CDI-988 has been awarded Fast Track Designation by the FDA, a designation given to drugs that treat serious conditions with no effective treatments. It is intended to streamline the clinical development and shorten regulatory review for products treating unmet medical needs. The designation should save Cocrystal time and clinical expenses, as well as give recognition to CDI-988 as a meaningful new vaccine for the prevention and treatment of norovirus. Read the full report here: https://www.channelchek.com/news-channel/cocrystal-pharma-cocp-cdi-988-receives-fast-track-designation-raising-its-profile

0 · Reply